Actuate Therapeutics Inc
ACTU | NASDAQ
$0.85
-$0.06 (-6.32%)
Sep 22, 2026, 12:59 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
PE Ratio | -5.77 | -2.44 | -5.22 | -6.43 |
PEG Ratio | 0.09 | -0.03 | -0.23 | n/a |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | 16.24 | 1.49K | -1.30 | 8.73 |
P/FCF Ratio | -6.70 | -7.11 | -5.99 | -7.27 |
P/OCF Ratio | -6.70 | -7.11 | -5.99 | -7.27 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | n/a | n/a | 0.03 |
Quick Ratio | 2.39 | 1.05 | 0.43 | 4.71 |
Current Ratio | 2.39 | 1.05 | 0.43 | 4.71 |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | -1.11K | 1.34K | -572.26 | -1.25K |
Return on Equity | -280.51% | -26.19K% | 24.84% | -135.92% |
Return on Assets | -158.36% | -292.81% | -826.04% | -98.42% |
Return on Invested Capital | -270.08% | -4.88K% | 636.27% | -125.21% |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ACTU